How Far Are We From Achieving Delabeling of False Penicillin/ß-Lactam Allergy Alerts? A Population Problem

• Published in: Journal of investigational allergology & clinical immunology Vol. 35; no. 1
• Main Authors: Tejedor-Alonso, M A, Perez-Encinas, M, Sanz Márquez, S, Martinez Simon, J J, Moreno-Nuñez, L, Gonzalez-Moreno, A, Macias-Iglesias, J, Rosado-Ingelmo, A
• Format: Journal Article
• Language: English
• Published: Spain 09.05.2024
• Subjects: Label; Allergy; Effectiveness; ß-Lactam; Barriers; Penicillin
• ISSN: 1018-9068
• DOI: 10.18176/jiaci.1004

Interest in finding efficient ways to remove penicillin allergy alerts has grown as a result of awareness of the considerable excess of false-negative diagnoses in patients with penicillin allergy labels (90%-95%), the poorer course with non-ß-lactam antibiotics, the increase in bacterial resistance, and the fact that these problems can affect up to 20% of the population in some countries. The strategies proposed have generated many publications in countries where the number of allergists to conduct such studies is low. In many cases where delabeling is performed, the risk of ß-lactam allergy is low, and a single penicillin challenge is sufficient to delabel the alert. However, other less "ultrarapid" strategies can be used to administer a ß-lactam during an admission for infection and thus postpone delabeling until traditional drug allergy consultations. However, the definitive withdrawal of ß-lactam alerts is threatened by nonremoval of alerts in electronic health records and by the reactivation or nonsynchronization of alerts between electronic systems at different levels of care. Allergy departments need to reflect on how to implement practices that enable rapid and efficient delabeling of drug allergy alerts, especially in patients with major comorbidities.